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In light of the emerging interplay between redox and metabolic signaling pathways we investigated the
potential cross talk between nuclear factor E2-related factor 2 (Nrf2) and AMP-activated kinase (AMPK),
central regulators of the cellular redox and energy balance, respectively. Making use of xanthohumol
(XN) as an activator of both the AMPK and the Nrf2 signaling pathway we show that AMPK exerts a
positive inﬂuence on Nrf2/heme oxygenase (HO)-1 signaling in mouse embryonic ﬁbroblasts. Genetic
ablation and pharmacological inhibition of AMPK blunts Nrf2-dependent HO-1 expression by XN already
at the mRNA level. XN leads to AMPK activation via interference with mitochondrial function and
activation of liver kinase B1 as upstream AMPK kinase. The subsequent AMPK-mediated enhancement of
the Nrf2/HO-1 response does not depend on inhibition of the mammalian target of rapamycin, inhibition
of glycogen synthase kinase 3β, or altered abundance of Nrf2 (total and nuclear). However, reduced
endoplasmic reticulum stress was identiﬁed and elaborated as a step in the AMPK-augmented Nrf2/HO-
1 response. Overall, we shed more light on the hitherto incompletely understood cross talk between the
LKB1/AMPK and the Nrf2/HO-1 axis revealing for the ﬁrst time involvement of the unfolded protein
response as an additional player and suggesting tight cooperation between signaling pathways
controlling cellular redox, energy, or protein homeostasis.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Generation and detoxiﬁcation of reactive oxygen species (ROS) are
tightly linked with the nutrient and metabolic status of a cell.
Likewise, oxidation of nutrients is linked with superoxide formation.
Reduced nicotinamide adenine dinucleotide phosphate (NADPH),
mainly derived from the pentose phosphate pathway, is a crucial
cosubstrate for enzymes involved in detoxiﬁcation (e.g., glutathione
reductase, thioredoxin reductase) and production (NADPH oxidases,
NO synthases) of reactive (oxygen) species or oxidation products. ROS-
forming enzymes alter their activity on phosphorylation, glycosylation,
or acetylation, all posttranslational modiﬁcations lastly dependent on
the cellular nutrient status (e.g., [1–3]).
On the level of individual players within the cellular redox balance,
nuclear factor E2-related factor 2 (Nrf2) is an accepted master regu-
lator. Nrf2 is a ubiquitously expressed transcription factor of the cap´n
´collar basic leucine zipper family, and constitutes a major part of the
cellular defense against oxidative but also other harmful insults. In
unstressed cells the level of Nrf2 protein is low which is usually
brought about by binding of Nrf2 to its most prominent inhibitor
Kelch-like ECH-associated protein (KEAP) 1 in a 1:2 molar ratio. Keap1,
being an adapter for Cul3/Rbx1 E3 ubiquitin ligases, facilitates constant
proteasome-dependent degradation of Nrf2. On exposure to oxidative
or electrophilic agents cysteine residues of Keap1 are oxid-
ized or covalently modiﬁed. This alters the conformation of the
Nrf2/ Keap1 complex, stops ubiquitination and degradation of Nrf2,
and favors its accumulation and subsequent nuclear translocation. In
the nucleus, Nrf2 heterodimerizes with small musculoaponeurotic
ﬁbrosarcoma (Maf) proteins and binds to antioxidant response
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element (ARE) consensus sequences (TCAG/CXXXGC) in promoters of
Nrf2-regulated genes. Those comprise approximately 200 genes
including heme oxygenase 1 (HO-1) and promote detoxiﬁcation of
the initial insult. Besides the canonical Keap1-dependent regulation
Nrf2 abundance is further controlled by degradation via the glycogen
synthase kinase 3β (GSK3 β)/β-transducin-repeat containing protein
(βTrcP) 1 pathway or synoviolin/Hrd1-ubiquitin ligase (Hrd1), by
altered tran-
scription of the Nrf2 gene or microRNAs targeting Nrf2. Posttransla-
tional modiﬁcations at the Nrf2 protein ﬁne-tune nuclear residence
and activity of Nrf2 and include phosphorylation or acetylation of Nrf2
or interaction of the transcription factor with distinct binding partners
[4–7]. Thus, the Nrf2-dependent cytoprotection pathway is able to
receive and integrate cues from multiple different signal transduction
pathways.
AMP-activated kinase (AMPK) is a central hub for cellular energy
homeostasis. The heterotrimeric serine/threonine kinase is formed by
the catalytic alpha and the regulatory beta and gamma subunits. Its
enzymatic activity is highly responsive to the cellular energy load.
Binding of AMP to the gamma subunit in cases of low energy alters
conformation and favors phosphorylation of Thr172 of the alpha
subunit mainly by liver kinase B1 (LKB1), resulting in a massive
increase of enzymatic activity of AMPK. Largely AMP-independent
phosphorylation and activation of AMPK can be mediated by calcium
calmodulin-dependent kinase kinase (CaMKK)β and transforming
growth factor β-activated kinase (TAK)1, rendering AMPK also suscep-
tible to stimuli beyond energy stress, such as increased intracellular
calcium levels [8–11]. Accordingly, activated AMPK elicits pleiotropic
effects including generally increased catabolism and decreased ana-
bolism, improved endothelial function, reduced inﬂammation, or
improved redox balance [12–14]. Notably, those phenotypic readouts
were also observed in numerous studies on activation of Nrf2 [15–18],
suggesting that Nrf2 and AMPK may cooperate within their signaling
networks.
Given the link between the cellular metabolic and redox state [4]
and the widely overlapping cellular responses on Nrf2 or AMPK
activation we set out to investigate a potential AMPK/Nrf2 cross talk
in molecular detail. We used wild-type (WT) and isogenic Nrf2 or
AMPK knockout mouse embryonic ﬁbroblasts (MEF) as well as
xanthohumol (XN), a prenylated chalcone from hops, as small mole-
cular probe mediating activation of both AMPK and Nrf2 [19–21].
Induction of HO-1, an enzyme decomposing heme to biliverdin, iron,
and CO2 and accounting for many beneﬁcial outcomes on Nrf2
activation (e.g., [22–24]), served as readout for Nrf2 activity.
Materials and methods
Cells, chemicals, and antibodies
Isogenic Nrf2-/- and WT mouse embryonic ﬁbroblasts (MEF) were
kindly provided from Thomas Kensler (University of Pittsburgh, PA,
USA), isogenic AMPKα-/- and WT MEF from Benoit Viollet (Institute
Cochin INSERM, Paris, France), and the LKB1-/- and WT MEF from
Reuben J. Shaw (Salk Institute, La Jolla, CA, USA) [25–27]. The clone of
Chinese hamster ovary (CHO) cells stably expressing the ARE-
dependent luciferase reporter (CHO-ARE-Luc) has been previously
described [28]. The primary antibodies directed against AMPKα (No.
2532), phospho-AMPKα (Thr172) (No. 2535), ACC (No. 3662),
phospho-ACC (Ser79) (No. 3661), LKB1 (No. 3047), lamin B1 (No.
13435), BiP (No. 3183), and α,β-tubulin (No. 2148) were from Cell
Signaling Technology (Danvers, MA, USA). The antibody against Nrf2
was from Santa Cruz (C-20; No. sc-722) (Dallas, TX, USA), the antibody
against HO-1 (No. ADI-SPA-896) from Enzo Life Sciences (Farmingdale,
NY, USA), and the antibody against actin (No. 69100) from MP
Biomedicals (Santa Ana, CA, USA). The secondary HRP-linked antibody
against rabbit was from Cell Signaling, the antibody against mouse
from MP Biomedicals. Xanthohumol, compound C, chloroquine,
phenylbutyrate, tunicamycin, and thapsigargin were purchased from
Sigma-Aldrich (St. Louis, MO, USA), rapamycin from Cell Signaling, and
CHIR99021 from Santa Cruz. The PERK inhibitor GSK2606414 came
from EMD Millipore (Darmstadt, Germany).
Cell cultivation and treatment
MEF and CHO-ARE-Luc were cultured in Dulbecco’s modiﬁed
essential medium (DMEM; Lonza, Braine-L’Alleud, Belgium) sup-
plemented with 10% heat inactivated fetal calf serum (FCS, Lonza)
and 2 mM glutamine (Invitrogen, Carlsbad, CA, USA) under a
humidiﬁed atmosphere of 5% CO2 at 37 1C. For all experiments
cells were reseeded in appropriate plates and grown to approxi-
mately 80–90% conﬂuence. During treatment with XN the serum
concentration was reduced to 2% in all wells (including control
wells) in order to avoid major adsorption of XN to serum proteins
[29]. Unless otherwise stated, all compounds were dissolved in
dimethyl sulfoxide (DMSO). The ﬁnal concentration of DMSO did
not exceed 0.2%.
ARE-luciferase reporter gene assay
CHO-ARE-LUC cells were treated as indicated for 8 h before
their lysates were subjected to assessment of luciferase activity as
previously described [28].
Preparation of whole cell lysates, SDS-PAGE, and Western blot
Cells were seeded in 6-well culture plates. After being treated as
indicated cells were lysed, and total cell lysates were subjected to SDS
polyacrylamide electrophoresis and immunoblot as described else-
where [30]. Detailed protocols can be found in the supplemental
information.
Fractionated extraction of nuclear and cytosolic proteins
Cells were grown in 6- or 10-cm dishes. Treated as indicated cells
were subjected to extraction of cytosolic and nuclear proteins as
described previously [16]. Detailed information can be found in the
supplemental material. Successful fractionation was conﬁrmed by a
lacking signal for lamin B1 in the cytosolic fraction and a missing
signal for tubulin in the nuclear fraction in the respective immunoblot.
Real-time quantitative polymerase chain reaction (RTqPCR)
Extraction of total RNA, reverse transcription, and quantitative PCR
and evaluation were performed as previously described [30]. Detailed
information can be found in the supplemental material. Primers for
murine HO-1 and the reference gene, murine hypoxanthine-phos-
phoribosyl-transferase (HPRT), came as QuantiTect Primer Assays from
Qiagen (Venlo, Netherlands).
Determination of the total intracellular ROS load
Levels of intracellular ROS were determined by ﬂow cytometric
assessment of dichloroﬂuorescein (DCF) ﬂuorescence as described
previously [30].
Determination of the reduced (GSH) and oxidized glutathione (GSSG)
The cellular ratio of GSSG/GSH was determined with the lumines-
cent GSSG-GSH Glo Assay from Promega (Madison, WI, USA) accord-
ing to the manufacturers’ instructions.
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Determination of mitochondrial superoxide production
Cells were incubated with 5 mM MitoSox Red (Invitrogen) for
15 min and then treated with vehicle, XN (5 mM), or antimycin A
(10 mM, positive control) for different periods of time. Then the red
ﬂuorescence (FL2 channel, ex 488 nm; em 585/42 nm) of 10,000 cells
was determined by ﬂow cytometry (FACS Calibur, BD Biosciences, San
Jose, CA, USA) and corrected for autoﬂuorescence. The obtained
arbitrary mean was taken as readout for produced mitochondrial
superoxide.
Determination of mitochondrial function by extracellular ﬂux analysis
MEF were seeded in appropriate collagen-coated 24-well cell
culture plates (from Seahorse Biosciences, Copenhagen, Denmark) at
a cell density of 2.7  104 cells/well. Cells were kept in serum-free
medium (glucose free DMEM plus 2 mM glutamine, 2 mM pyruvate,
pH 7.35–7.40) at 37 1C and ambient CO2 for 1 h before they were
subjected to mitochondrial (readout: oxygen consumption rate (OCR)
in pmol O2/ min) stress tests. Appropriate test kits came from Seahorse
Biosciences, were performed according to the manufacturers´ instruc-
tions, and analyzed on a Seahorse 24XFe extracellular ﬂux analyzer
and Wave software (www.seahorsebio.com) as described elsewhere
[31] and in detail in the supplemental information.
Statistics
Experiments were performed at least three times. Error bars in the
pictures represent the SD (standard deviation) of the mean. Statistical
signiﬁcance was determined by using Student’s t test or by one-way
ANOVA followed by Bonferroni’s post test. All statistical analyses were
done with GraphPad Prism. P values o0.05 were considered as
signiﬁcant and are designated with n in the ﬁgures.
Results
AMPK boosts the Nrf2-mediated HO-1 induction by XN
In order to conﬁrm the previously reported XN-triggered Nrf2 and
AMPK activation in our hands we determined ARE-dependent
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Fig. 1. XN leads to activation of AMPK and Nrf2 and triggers HO-1 induction in a strictly Nrf2-dependent manner in MEF. (A) CHO-ARE-Luc cells were treated with vehicle or
5 mM xanthohumol (XN, Xn; upper panel) for 8 h before their luciferase expression was assessed. Bar graph depicts compiled data from three independent experiments
expressed as fold activation compared to vehicle control (mean þ SD; n Po0.05; ANOVA). (B) WT MEF cells were treated with vehicle or XN (5 mM) for 30 min before total
cell lysates were subjected to immunoblot analyses for pAMPK (T172), total AMPK, pACC (S79), and total ACC. Representative blots and compiled densitometric analyses of
three independent experiments are depicted (mean þ SD; n Po0.05; Student’s t test). (C) WT and Nrf2-/- MEF were treated with XN (5 mM) for the indicated periods of time
before total cell lysates were subjected to immunoblot analysis for HO-1 and actin, respectively. Respective blots of three independent experiments are depicted with the bar
graph showing compiled densitometric data from all performed experiments (mean þ SD; n Po 0.05; ANOVA, to vs tx). (D) WT and Nrf2-/- MEF were treated with vehicle
(DMSO, D) or XN (5 mM) for 4 h before their mRNA was isolated and subjected to qPCR analysis for quantiﬁcation of HO-1 (target) and HPRT (reference) transcripts. The bar
graph shows compiled data of three independent experiments expressed as fold HO-1 induction (normalized to HPRT levels) on XN exposure (mean þ SD; nPo0.05;
Student´s t test).
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luciferase expression and AMPK activation on exposure to XN, resp-
ectively. XN signiﬁcantly activated Nrf2 and induced ARE-dependent
luciferase expression at a concentration of 5 mM (Fig. 1A). Moreover,
5 mM XN led to AMPK activation as evident by elevated phosphoryla-
tion of AMPK at Thr172 and of acetyl-CoA-carboxylase (ACC) at Ser79,
a downstream target of AMPK (Fig. 1B). Administration of XN to MEF
cells revealed a time-dependent increase of HO-1 protein expression
in WT cells. Upregulation of the protein started already after 3 h,
reached a maximum after 7 h, and declined after 24 h. Isogenic Nrf2-/-
MEF completely failed to induce HO-1 on exposure to XN, indicating
that HO-1 induction by XN is a strictly Nrf2-dependent process
(Fig. 1C). The Nrf2 dependency could be conﬁrmed at the level of
HO-1 mRNA (Fig. 1D). XN led to a vigorous induction of HO-1 mRNA in
WT, but not at all in Nrf2-/- cells. These data validated our model
system based on XN as activator of the AMPK and Nrf2 signaling
pathway and on HO-1 as exclusively Nrf2-dependent readout.
We then addressed the question whether activated AMPK inﬂu-
ences Nrf2-dependent HO-1 induction using WT and AMPK-/- MEF.
XN time dependently induced HO-1 in WT cells, again with a
maximum at around 7 h after exposure. AMPK-/- cells also responded
to XN with induction of HO-1, with similar kinetics but reduced
amplitude compared to WT cells. Thus, AMPK is not pivotal for, but
increases, the strength of the cellular Nrf2/HO-1 response after XN
treatment. The reduced response in AMPK-/- cells became evident on
both the protein and the mRNA level (Fig. 2A and B). Experiments
using actinomycin D, a transcriptional inhibitor, revealed that the half-
life of HO-1mRNA is not markedly different betweenWTand AMPK-/-
cells (Suppl. Fig. S1), excluding a major impact of AMPK on HO-1
mRNA stability. In line with the genetic knockout of AMPK cotreat-
ment of WT cells with the AMPK inhibitor compound C signiﬁcantly
reduced the XN-triggered HO-1 induction on the protein (Fig. 2C) and
mRNA level (Fig. 2D). These ﬁndings indicate that activated AMPK
exerts a positive impact on the Nrf2-mediated HO-1 induction at a
step prior to or at mRNA production.
XN activates AMPK and boosts Nrf2 signaling in an LKB1-dependent
manner
Before investigating in more detail the AMPK-mediated
boost of Nrf2 signaling we examined how XN leads to AMPK
activation. XN has been reported to interfere with proper
mitochondrial function and ATP production in various cell
systems [32,33]. Using extracellular ﬂux analysis we observed
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Fig. 2. AMPK boosts the Nrf2-mediated HO-1 induction by XN. (A) WT and AMPK-/- MEF were treated with XN (5 mM) for the indicated periods of time before total cell
lysates were subjected to immunoblot analysis for HO-1, AMPK, and actin, respectively. Representative blots of three independent experiments are depicted with the bar
graph showing compiled densitometric data from all performed experiments (mean þ SD; n Po 0.05; ANOVA). (B) WT and AMPK-/- MEF were treated with vehicle (DMSO,
D) or XN (5 mM) for 4 h before their mRNA was isolated and subjected to qPCR analysis for quantiﬁcation of HO-1 (target) and HPRT (reference) transcripts. The bar graph
shows compiled data of three independent experiments expressed as fold HO-1 induction (normalized to HPRT levels) on XN exposure (mean þ SD; n Po0.05; ANOVA). (C
and D) WT MEF were treated with the AMPK inhibitor compound C (10 mM; CC) for 30 min and then with XN (5 mM) for 7 h (C) or 4 h (D) before their HO-1 expression was
determined by immunoblot (C) or qPCR (D). Bar graphs depict compiled data from three independent experiments (mean þ SD; n Po0.05; ANOVA). representative blots
are shown.
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reduced basal respiration and reduced oxygen consumption
for ATP synthesis, as well as decreased maximal and spare
respiratory capacities in XN-treated MEF compared to control
cells (Fig. 3A, Suppl. Fig S2A (raw data)). XN per se did not act
as FCCP-like uncoupler (i.e., direct dissipator of the mitochon-
drial proton gradient) in MEF (Suppl. Fig. S2B), but led to an
elevated production of mitochondrial superoxide (Suppl. Fig.
S2C). These data suggest that XN at 5 mM acts as inhibitor of
the electron transport chain in MEF rather than as uncoupler
as suggested by Kirkwood and coauthors using myo-, hepato-,
and preadipocytes [32]. Reduced mitochondrial function can
go along with a reduced ATP/AMP ratio, activation with LKB1,
and subsequent phosphorylation and activation of AMPK
[10,34]. We therefore examined the involvement of LKB1 in
the XN-induced AMPK activation. Using WT and LKB1-/- MEF
revealed that XN increases the phosphorylation of both AMPK
at Thr172 and ACC at Ser79 in WT cells but not in the LKB1-/-
cells (Fig. 3B). Furthermore, compared to WT the XN-
dependent upregulation of HO-1 is blunted in LKB1-/- cells
(Fig. 3C), reminiscent of the observations made in AMPK-/-
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Fig. 3. XN impairs mitochondrial function and activates AMPK in an LKB-1-dependent manner. (A) Mitochondrial function was assessed in vehicle and XN (5 mM)-treated
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treated with vehicle or XN (5 mM) for 30 min before total cell lysates were subjected to immunoblot analyses for pAMPK (T172), total AMPK, pACC (S79), total ACC and LKB1.
Representative blots and compiled densitometric analyses of three independent experiments are depicted (mean þ SD; n Po0.05; Student’s t test). (C) WT and LKB1-/- MEF
were treated with XN (5 mM) for the indicated periods of time before total cell lysates were subjected to immunoblot analyses for HO-1, LKB1, and actin. Representative blots
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cells. These data indicate that LKB-1 is upstream of AMPK to
boost Nrf2 signaling, and XN is likely to interfere with the
mitochondrial electron transport chain in MEF.
WT and AMPK-/- MEF do not differ in their level of oxidative stress
under basal and XN-exposed conditions
AMPK has already been reported as a positive upstream regulator
of Nrf2 in C. elegans [35]. In that study AMPK activation was shown to
lead to an elevated rate of mitochondrial respiration, a subsequently
increased mitochondrial superoxide production, and ﬁnally to an
increased Nrf2 activity as cellular adaptive response to the AMPK-
driven rise in intracellular redox stress (mitohormesis). We therefore
checked whether different levels of basal and XN-induced ROS levels
between WT and AMPK-/- cells could account for the observed
distinct strength of Nrf2-mediated HO-1 induction. We examined
total ROS (Fig. 4A) and mitochondrial superoxide (Fig. 4B) levels as
well as the ratio between GSSG and GSH (Fig. 4C) under basal
conditions and on exposure to XN. Acute administration of XN led
to an increase in ROS levels, however, to the same extent in both
investigated cell types. Moreover, WT and AMPK-/- did not differ in
their basal ROS load and showed a comparable doubling time of about
15–16 h, largely excluding altered proliferation-related redox stress as
explanation for the distinct Nrf2 response [36]. The observed AMPK-
mediated boost of XN-induced Nrf2 signaling cannot be explained by
an altered cellular redox balance.
The positive effect of activated AMPK on Nrf2 signaling does not
involve inhibition of mTOR or GSK3β
AMPK shifts cellular signal transduction toward a direction
with potential positive impact on the Nrf2 pathway. Activated
AMPK favors autophagy which, in turn, has been involved in
augmented Nrf2 levels and signaling in some reports [37,38]. We
assessed whether autophagy constitutes the signaling interface
on which the observed AMPK/Nrf2 cross talk takes place. Mam-
malian target of rapamycin (mTOR) is one of the major upstream
inhibitors of autophagy and is inhibited by phosphorylation by
AMPK [39]. If activated AMPK mediates its boost on Nrf2 signal-
ing by mTOR inhibition and autophagy activation, rapamycin, an
inhibitor of mTOR, should rescue the blunted XN response in
AMPK-/- cells. However, treatment with rapamycin reduced
rather than increased XN-mediated increased HO-1 protein levels
in AMPK-/- cells. The same behavior was observed in WT cells,
probably due to generally impaired protein synthesis on rapa-
mycin exposure owing to interference with ribosomal protein S6
kinase 1 activity (Fig. 5A). Inhibition of autophagy by the
lysosomal inhibitor chloroquine did not show any effect on the
XN-induced HO-1 levels in WT or AMPK-/- cells either (Fig. 5B).
Thus, based on these data with pharmacological activators and
inhibitors altered mTOR activity or autophagy does not occur as
an obvious explanation for the AMPK-mediated enhancement of
Nrf2 signaling and HO-1 protein expression. However, thinking of
the complex regulation of autophagy additional experiments are
needed to unambiguously corroborate this conclusion. AMPK also
inactivates GSK3β by phosphorylation, and GSK3β negatively
inﬂuences Nrf2 signaling by increased Nrf2 degradation via the
βTrcP pathway or increased nuclear exclusion [40–43]. It is
therefore conceivable that AMPK-mediated GSK3β inhibition
accounts for the higher Nrf2 response in WT than in AMPK-/-
cells. However, inhibition of GSK3β by CHIR9921 (Fig. 5C),
lithium chloride, or siRNA-mediated knockdown (data not
shown) did not signiﬁcantly elevate HO-1 levels in AMPK-/- cells,
largely excluding GSK3β as mediator between AMPK and Nrf2 in
the used test system.
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Fig. 5. Inhibition of mTOR or of GSK3β does not play an obvious role in the AMPK-mediated boost of Nrf2-mediated HO-1 induction. WT and AMPK-/- MEF were pretreated
with the mTOR inhibitor rapamycin (Rap; 100 nM) (A), the autophagy inhibitor chloroquine (chloro; 10 and 50 mM) (B), or the GSK3β inhibitor CHIR99201 (CHIR; 10 mM)
(C) for 30 min before they were incubated with XN (5 mM) for 7 h. Total cell lysates were subjected to an immunoblot analysis for HO-1 and actin. Representative blots and
compiled densitometric data of three independent experiments are depicted (mean þSD; nPo 0.05, ANOVA).
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Fig. 6. WT and AMPK-/- MEF do not differ in their total and nuclear levels of Nrf2 on XN exposure. (A) WT and AMPK-/- MEF were treated with vehicle or XN (5 mM) for 4 h
before total cell lysates were subjected to immunoblot analysis for Nrf2 and α⧸β tubulin. (B) WT and AMPK-/- MEF were treated with XN (5 mM) for the indicated periods of
time before nuclear extracts were subjected to immunoblot analysis for Nrf2 and lamin B1. Representative blots from three independent experiments and compiled
densitometric data are depicted (mean þ SD; nPo0.05; ANOVA).
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WT and AMPK-/- cells do not differ in their total or nuclear level of
Nrf2 on XN treatment
Transcriptional activity of Nrf2 is highly regulated via degradation
and/or nuclear import [7,44]. The blunted Nrf2 response in AMPK-/-
cells could therefore still be due to reduced total or nuclear levels of
Nrf2 in these cells, mediated by players other than GSK3β or mTOR.
However, experiments assessing total levels and time-dependent
nuclear translocation of Nrf2 in WT and AMPK-/- cells did not reveal
signiﬁcant differences in total level of the transcription factor (Fig. 6A)
or in its nuclear accumulation on XN treatment (Fig. 6B). Overall, these
data indicate that the positive effect of AMPK on Nrf2-mediated
transcription in our system does not imply altered abundance or
nuclear translocation of Nrf2.
AMPK-/- cells show an elevated ER stress that hampers
Nrf2-mediated HO-1 induction
Nrf2 not only alleviates stress imposed by oxidative damage but
also by xenobiotics, nutritional imbalance, growth factors, or accumu-
lation of unfolded proteins in the endoplasmic reticulum (ER). The
latter merges in a cellular defense program called unfolded protein
response (UPR) counteracting ER stress primarily by inhibition of
translation and activation of protein degradation. Recent studies
suggest a vivid cross talk between the oxidative stress and the
unfolded protein response, also with regard to Nrf2 signaling [45–
47]. Of note, activated AMPK has been reported to alleviate ER stress
[48,49]. We therefore were prompted to test whether altered ER stress
could possibly explain the AMPK-triggered boost of HO-1 induction.
Fig. 7A shows that AMPK-/- display higher levels of GRP78/BiP, a
protein accumulating on ER stress. Induction of ER stress by tunica-
mycin, a glycosylation inhibitor, or thapsigargin, an inhibitor of ER
Ca2þ-ATPase, reduced the XN-launched HO-1 expression in WT, but
not AMPK-/- cells (Fig. 7B). Alleviation of ER stress by phenylbutyrate
(Suppl. Fig. S3) was able to increase HO-1 expression in AMPK-/- but
not WT cells (Fig. 7C). A consistent picture arose when cells were
treated with GSK260641, an inhibitor of ER-resident protein kinase
RNA-like endoplasmic reticulum kinase (PERK) controlling one of the
three branches of the UPR [50] (Fig. 7D). These data demonstrate
distinct levels of ER stress signaling between WT and AMPK-/- cells
which relates to the different strength of Nrf2-mediated HO-1
expression and involves the PERK branch of the UPR.
Discussion
In this work we made use of XN as small molecular probe acti-
vating both AMPK and Nrf2 signaling and analyzed the Nrf2/HO-1
response dependent on AMPK. Administration of XN to WT and
AMPK-/- MEF showed a robust positive inﬂuence of AMPK on Nrf2-
mediated HO-1 expression at the level of HO-1 mRNA and protein.
AMPK deﬁciency accounted for elevated ER stress which was asso-
ciated with increased PERK activity and subsequently reduced HO-1
expression. Total and nuclear levels of Nrf2 in WT and AMPK-/- cells
were comparable. Moreover, AMPK activation by XN could be
associated with mitochondrial dysfunction and for the ﬁrst time with
LKB1 as upstream AMPK kinase.
During the course of our work an AMPK-mediated enhancement of
Nrf2 signaling has been reported by other investigators. Mo and
coauthors observed a positive inﬂuence of AMPK on the berberine-
induced Nrf2 response in septic mice [51]. Lee and Kim noted a
reduced Nrf2 response on dehydrodiconiferyl alcohol (DHCA) expo-
sure in macrophages when the AMPK inhibitor compound C is
coadministered [52]. However, molecular details underlying the cross
talk in those models remained largely elusive. For the model system
used in this study, we could exclude increased intracellular redox
stress and inhibition of mTOR or GSK3β to markedly contribute to the
AMPK-mediated boost of Nrf2-mediated HO-1 induction. Regarding
the role of GSK3β as a downstream target of AMPK, it must be
stressed that our cellular system runs in 2–10% fetal calf serum and,
thus, under conditions in which GSK3β is already signiﬁcantly inh-
ibited by the contained growth factors. Moreover, XN activates Nrf2
largely in a Keap1 rather than a GSK3β /βTrcP-dependent manner
([20] and Suppl. Fig. S4). Both system-inherent parameters override
possible effects of the AMPK/GSK axis on Nrf2 which may apply in
other systems based on quiescent cells or Keap1-independent Nrf2
activators and deserves further investigation.
The cellular UPR inﬂuences the oxidative stress response and
vice versa on multiple levels. On the one hand, increased ER stress
goes along with activation of PERK that is reported to phosphor-
ylate and activate Nrf2 [53]. On the other hand, the ER stress-
related ubiquitin ligase synoviolin/Hrd1 was found to trigger
degradation and inactivation of Nrf2 [5]. In C. elegans several
components of the UPR are target genes of SKN-1, the homologue
of Nrf2, and signaling from the ER was shown to be necessary for
the response of SKN-1 to oxidative stress [47]. In addition and of
particular interest for our model system, activation of AMPK was
found to activate the unfolded protein response [54] and to lower
ER stress induced by various stressors [49]. In line with this
emerging cross talk among AMPK, ER stress, and oxidative stress
response we could link the three players for the ﬁrst time.
AMPK-/- MEF suffered from elevated ER stress which, in turn,
contributed to the reduced Nrf2-mediated HO-1 expression com-
pared to WT cells. Accordingly, induction of ER stress in WT or
alleviation of ER stress in AMPK-/- cells approximated the extent of
XN-triggered HO-1 induction between both cell types. It will be of
interest to further investigate how AMPK signals to the individual
branches of the UPR—the inositol-requiring protein 1 (IRE1), PERK,
or activating transcription factor (ATF)6 branch [50,55]—in order
to control Nrf2 activity. Using pharmacological inhibition we could
already show that elevated PERK activity contributes to the
reduced strength of the Nrf2/HO-1 axis in AMPK-deﬁcient cells.
The effect of PERK on Nrf2 activity seems to be context dependent.
In cells lacking an AMPK signal PERK dampens the Nrf2/HO-1
signaling axis whereas in cells with AMPK PERK activity generally
exerts an activating inﬂuence on the Nrf2 response ([45,53]; see
also Fig. 7D: no signiﬁcant but reproducible trend of reduced HO-1
induction in WT cells on inhibition of PERK).
Despite slightly higher levels of the ER stress-linked ubiquitin
ligase Hrd1 (see Suppl. Fig. S5) AMPK-/- cells do not show reduced
Nrf2 levels compared to WT MEF. Kinetics and quantity of total
and nuclear Nrf2 accumulation on XN exposure showed no
dependency on the presence of AMPK. Thus, activated AMPK and
ER homeostasis seem to positively inﬂuence Nrf2-mediated HO-1
mRNA production in the nucleus. This could be mediated on the
molecular level, e.g., by altered posttranslational modiﬁcation of
Nrf2, altered binding partners in the coactivator complex, or
altered binding behavior at ARE-dependent promoters (duration,
strength, preference for certain promoters). Xue et al. recently
suggested that amplitude and frequency of constitutive Nrf2
oscillations between cytosol and nucleus are determinants for
Nrf2-mediated gene transcription, independently from Nrf2 abun-
dance [56]. Future studies are warranted to scrutinize in detail the
role of AMPK and ER stress for those features in the Nrf2 signaling
pathway. A competition between the UPR and the oxidative stress
response for Nrf2´s transcriptional activity has been suggested for
C. elegans [47]. It is tempting to speculate that such competition
explains our ﬁndings. Current studies investigate whether Nrf2 of
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AMPK-deﬁcient cells is preferentially targeted to promoters of
genes connected with the unfolded protein response in disfavor of
those genes mainly involved in the oxidative stress response such
as HO-1.
Overall, using a chemical biological approach we showed the
positive inﬂuence of AMPK on Nrf2/HO-1 signaling and revealed a
hitherto unknown involvement of the PERK branch of the UPR in the
signaling axis between AMPK and Nrf2/HO-1. These ﬁndings made
in MEF may prompt further exploration of Nrf2 as a general sensor
and executor of the cellular redox, energy, and protein homeostasis
in specialized cell, organ, or whole animal systems. Furthermore, the
demonstrated cooperation between the LKB1/AMPK and Nrf2/HO-1
axis may provide an important step in the etiology of metabolic
disease or life span prolongation by caloric restriction.
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Fig. 7. Increased ER stress and PERK activity hamper Nrf2-mediated HO-1 induction in AMPK-/- cells. (A) Total cell lysates of WT and AMPK-/- cells were subjected to
immunoblot analysis for GRP78/BiP and actin. The graph on the right depicts compiled data of six independently prepared protein extracts. (n Po0.05; Student´s t test (WT
vs AMPK-/-).) (B) WT and AMPK-/-MEF were pretreated with the indicated concentrations of the ER stress inducers thapsigargin (Thaps) and tunicamycin (Tun) for 30 min
and then exposed to vehicle or XN (5 mM) for 7 h. Total cell lysates were subjected to immunoblot analysis for HO-1 and actin. Representative blots are depicted and the
graphs on the right show compiled densitometric data of three independent experiments (using Thaps at 3 mM and Tun at 5 mg/mL) (mean þ SD; n Po0.05; ANOVA). (C) WT
and AMPK-/- MEF were treated with phenylbutyrate (PB, 10 mM), an ER stress inhibitor, and exposed to vehicle or XN (5 mM) for 7 h as indicated before total cell lysates were
subjected to immunoblot analysis for HO-1 and actin. Representative blots are depicted and the graph on the right shows compiled densitometric data of three independent
experiments (mean þ SD; n Po0.05; ANOVA). (D) WT and AMPK-/- MEF were treated with 1 mM PERK inhibitor GSK 2606414 (PERKI) for 30 min before they were exposed
to XN (5 mM) for 7 h. Total cell lysates were subjected to immunoblot analysis for HO1 and actin. Representative blots and graphs showing the compiled densitometric
analyses of three independent experiments are depicted (mean þ SD; n Po0.05; ANOVA). The dashed line in the blot picture symbolizes cutout of interjacent bands of no
interest; all bands originate from the same membrane.
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